Fexofenadine Hydrochloride News
Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 ... - PharmaLive.com (press release)
... 2007 primarily reflects a decline in income derived from the Company's share of the profits from sales of fexofenadine hydrochloride tablets from Teva, ...
Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 ... - PR Newswire (press release)
... 2007 primarily reflects a decline in income derived from the Company's share of the profits from sales of fexofenadine hydrochloride tablets from Teva, ...
Fexofenadine safe and well tolerated in young children with ... - Therapeutics Daily (subscription) (press release)
NEW YORK (Reuters Health) - Fexofenadine hydrochloride has a good safety profile in treating allergic rhinitis in children 6-24 months of age, ...
Barr Reports Third Quarter 2007 GAAP Earnings of $0.36 Per Share ... - PR Newswire (press release)
... which offset a decrease in income derived from the Company's share of the profits from sales of fexofenadine hydrochloride tablets from Teva ...
Recent patent/copyright infringement cases filed in US District Court, - Southeast Texas Record
"On information and belief, Mylan's Fexofenadine Products contain Form II hydrated fexofenadine hydrochloride," the plaintiff's complaint states. ...
Ranbaxy Receives Tentative FDA Approval for Fexofenadine ... - Equity Bulls
Total annual market sales for Fexofenadine Hydrochloride Tablets were $931 million. Fexofenadine Hydrochloride is indicated for the relief of symptoms ...
Ranbaxy receives tentative FDA approval for Fexofenadine ... - Prdomain Business Register (press release)
Total annual market sales for Fexofenadine Hydrochloride Tablets were $931 million (IMS – MAT: March 2007). Fexofenadine Hydrochloride is indicated for the ...
Minus itch and irregular hear beats - Sun.Star
Fexofenadine hydrochloride is currently onto clinical trials in a hope to replace Terfenadine in treating allergic rhinitis. It is the active metabolite of ...
Ranbaxy gets USFDA approval for anti-allergic drug - Hindu
Total annual market sales for Fexofenadine Hydrochloride Tablets were pegged at 931 million dollars and the nod will further expand the company's product ...
FDA gives Ranbaxy tentative OK for generic drug - Bizjournals.com
Ranbaxy will market tablets of fexofenadine hydrochloride in doses of 30, 60 and 180 milligrams. Total annual market sales of the drug are $931 million. ...
Fexofenadine Hydrochloride RSS Feed